SEARCH

SEARCH BY CITATION

References

  • Abdelrahman AM, Pang CC (2006). Effect of intermedin/adrenomedullin-2 on venous tone in conscious rats. Naunyn Schmiedebergs Arch Pharmacol 373: 376380.
  • Abdelrahman AM, Pang CC (2007). Vasodilator mechanism of intermedin/adrenomedullin-2 in anesthetized rats. Proc West Pharmacol Soc 50: 4346.
  • Burak Kandilci H, Gumusel B, Wasserman A, Witriol N, Lippton H (2006). Intermedin/adrenomedullin-2 dilates the rat pulmonary vascular bed: dependence on CGRP receptors and nitric oxide release. Peptides 27: 13901396.
  • Chang CL, Roh J, Hsu SY (2004). Intermedin, a novel calcitonin family peptide that exists in teleosts as well as in mammals: a comparison with other calcitonin/intermedin family peptides in vertebrates. Peptides 25: 16331642.
  • Chauhan M, Ross GR, Yallampalli U, Yallampalli C (2007). Adrenomedullin-2, a novel calcitonin/calcitonin-gene-related peptide family peptide, relaxes rat mesenteric artery: influence of pregnancy. Endocrinology 148: 17271735.
  • Chiba T, Yamaguchi A, Yamatani T, Nakamura A, Morishita T, Inui T et al. (1989). Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am J Physiol 256: E331E335.
  • Christopoulos G, Perry KJ, Morfis M, Tilakaratne N, Gao Y, Fraser NJ et al. (1999). Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol 56: 235242.
  • Dong F, Taylor MM, Samson WK, Ren J (2006). Intermedin (adrenomedullin-2) enhances cardiac contractile function via a protein kinase C- and protein kinase A-dependent pathway in murine ventricular myocytes. J Appl Physiol 101: 778784.
  • Fujisawa Y, Nagai Y, Miyatake A, Takei Y, Miura K, Shoukouji T et al. (2004). Renal effects of a new member of adrenomedullin family, adrenomedullin2, in rats. Eur J Pharmacol 497: 7580.
  • Fujisawa Y, Nagai Y, Miyatake A, Miura K, Shokoji T, Nishiyama A et al. (2006). Roles of adrenomedullin 2 in regulating the cardiovascular and sympathetic nervous systems in conscious rats. Am J Physiol Heart Circ Physiol 290: H1120H1127.
  • Grossini E, Molinari C, Mary DA, Uberti F, Caimmi PP, Vacca G (2008). Intracoronary intermedin 1-47 augments cardiac perfusion and function in anesthetized pigs: role of calcitonin receptors and beta-adrenoreceptor-mediated nitric oxide release. J Appl Physiol 107: 10371050.
  • Hashimoto H, Hyodo S, Kawasaki M, Mera T, Chen L, Soya A et al. (2005). Centrally administered adrenomedullin 2 activates hypothalamic oxytocin-secreting neurons, causing elevated plasma oxytocin level in rats. Am J Physiol Endocrinol Metab 289: E753E761.
  • Hashimoto H, Hyodo S, Kawasaki M, Shibata M, Saito T, Suzuki H et al. (2007). Adrenomedullin 2 (AM2)/intermedin is a more potent activator of hypothalamic oxytocin-secreting neurons than AM possibly through an unidentified receptor in rats. Peptides 28: 11041112.
  • Hay DL, Howitt SG, Conner AC, Doods H, Schindler M, Poyner DR (2002). A comparison of the actions of BIBN4096BS and CGRP(8-37) on CGRP and adrenomedullin receptors expressed on SK-N-MC, L6, Col 29 and Rat 2 cells. Br J Pharmacol 137: 8086.
  • Hay DL, Howitt SG, Conner AC, Schindler M, Smith DM, Poyner DR (2003). CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS. Br J Pharmacol 140: 477486.
  • Hay DL, Christopoulos G, Christopoulos A, Poyner DR, Sexton PM (2005). Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes. Mol Pharmacol 67: 16551665.
  • Jolly L, March JE, Kemp PA, Bennett T, Gardiner SM (2009). Mechanisms involved in the regional haemodynamic effects of intermedin (adrenomedullin 2) compared with adrenomedullin in conscious rats. Br J Pharmacol 157: 15021513.
  • Kandilci HB, Gumusel B, Lippton H (2008). Intermedin/adrenomedullin-2 (IMD/AM2) relaxes rat main pulmonary arterial rings via cGMP-dependent pathway: role of nitric oxide and large conductance calcium-activated potassium channels (BK(Ca). Peptides 29: 13211328.
  • Kindt F, Wiegand S, Loser C, Nilles M, Niemeier V, Hsu SY et al. (2007). Intermedin: a skin peptide that is downregulated in atopic dermatitis. J Invest Dermatol 127: 605613.
  • Lin Chang C, Roh J, Park JI, Klein C, Cushman N, Haberberger RV et al. (2005). Intermedin functions as a pituitary paracrine factor regulating prolactin release. Mol Endocrinol 19: 28242838.
  • Mittra S, Bourreau JP (2006). Gs and Gi coupling of adrenomedullin in adult rat ventricular myocytes. Am J Physiol Heart Circ Physiol 290: H1842H1847.
  • Morimoto R, Satoh F, Murakami O, Totsune K, Suzuki T, Sasano H et al. (2007). Expression of adrenomedullin2/intermedin in human brain, heart, and kidney. Peptides 28: 10951103.
  • Morimoto R, Satoh F, Murakami O, Hirose T, Totsune K, Imai Y et al. (2008). Expression of adrenomedullin 2/intermedin in human adrenal tumors and attached non-neoplastic adrenal tissues. J Endocrinol 198: 175183.
  • Nag K, Kato A, Nakada T, Hoshijima K, Mistry AC, Takei Y et al. (2006). Molecular and functional characterization of adrenomedullin receptors in pufferfish. Am J Physiol Regul Integr Comp Physiol 290: R467R478.
  • Ogoshi M, Inoue K, Takei Y (2003). Identification of a novel adrenomedullin gene family in teleost fish. Biochem Biophys Res Commun 311: 10721077.
  • Owji AA, Chabot JG, Dumont Y, Quirion R (2008). Adrenomedullin-2/intermedin induces cAMP accumulation in dissociated rat spinal cord cells: evidence for the existence of a distinct class of sites of action. J Mol Neurosci 35: 355361.
  • Pan CS, Yang JH, Cai DY, Zhao J, Gerns H, Yang J et al. (2005). Cardiovascular effects of newly discovered peptide intermedin/ adrenomedullin 2. Peptides 26: 16401646.
  • Pfeil U, Aslam M, Paddenberg R, Quanz K, Chang CL, Park JI et al. (2009). Intermedin/adrenomedullin-2 is a hypoxia-induced endothelial peptide that stabilizes pulmonary microvascular permeability. Am J Physiol Lung Cell Mol Physiol 297: L837L845.
  • Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W et al. (2002). International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54: 233246.
  • Qi T, Christopoulos G, Bailey RJ, Christopoulos A, Sexton PM, Hay DL (2008). Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function. Mol Pharmacol 74: 10591071.
  • Qi T, Ly K, Poyner DR, Christopoulos G, Sexton PM, Hay DL (2011). Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors. Peptides 32: 10601067.
  • Ren YS, Yang JH, Zhang J, Pan CS, Yang J, Zhao J et al. (2006). Intermedin 1-53 in central nervous system elevates arterial blood pressure in rats. Peptides 27: 7479.
  • Robinson SD, Aitken JF, Bailey RJ, Poyner DR, Hay DL (2009). Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors; identification, pharmacological characterization and interactions with position 74 in RAMP1/3. J Pharmacol Exp Ther 331: 513521.
  • Roh J, Chang CL, Bhalla A, Klein C, Hsu SY (2004). Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activitymodifying protein receptor complexes. J Biol Chem 279: 72647274.
  • Shimekake Y, Nagata K, Ohta S, Kambayashi Y, Teraoka H, Kitamura K et al. (1995). Adrenomedullin stimulates two signal transduction pathways, cAMP accumulation and Ca2+ mobilization, in bovine aortic endothelial cells. J Biol Chem 270: 44124417.
  • Song JQ, Teng X, Cai Y, Tang CS, Qi YF (2009). Activation of Akt/GSK-3beta signaling pathway is involved in intermedin(1-53) protection against myocardial apoptosis induced by ischemia/reperfusion. Apoptosis 14: 12991307.
  • Takahashi K, Kikuchi K, Maruyama Y, Urabe T, Nakajima K, Sasano H et al. (2006). Immunocytochemical localization of adrenomedullin 2/intermedin-like immunoreactivity in human hypothalamus, heart and kidney. Peptides 27: 13831389.
  • Takahashi K, Morimoto R, Hirose T, Satoh F, Totsune K (2011). Adrenomedullin 2/intermedin in the hypothalamo-pituitaryadrenal axis. J Mol Neurosci 43: 182192.
  • Takei Y, Hyodo S, Katafuchi T, Minamino N (2004a). Novel fish-derived adrenomedullin in mammals: structure and possible function. Peptides 25: 16431656.
  • Takei Y, Inoue K, Ogoshi M, Kawahara T, Bannai H, Miyano S (2004b). Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator. FEBS Lett 556: 5358.
  • Takei Y, Hashimoto H, Inoue K, Osaki T, Yoshizawa-Kumagaye K, Tsunemi M et al. (2008). Central and peripheral cardiovascular actions of adrenomedullin 5, a novel member of the calcitonin gene-related peptide family, in mammals. J Endocrinol 197: 391400.
  • Taylor MM, Samson WK (2005). Stress hormone secretion is altered by central administration of intermedin/adrenomedullin-2. Brain Res 1045: 199205.
  • Taylor MM, Bagley SL, Samson WK (2005). Intermedin/adrenomedullin-2 acts within central nervous system to elevate blood pressure and inhibit food and water intake. Am J Physiol Regul Integr Comp Physiol 288: R919R927.
  • Taylor MM, Bagley SL, Samson WK (2006). Intermedin/Adrenomedullin-2 inhibits growth hormone release from cultured, primary anterior pituitary cells. Endocrinology 147: 859864.
  • White MM, Samson WK (2007). Intermedin 17-47 does not function as a full intermedin antagonist within the central nervous system or pituitary. Peptides 28: 21712178.
  • Wunder F, Rebmann A, Geerts A, Kalthof B (2008). Pharmacological and kinetic characterization of adrenomedullin 1 and calcitonin gene-related peptide 1 receptor reporter cell lines. Mol Pharmacol 73: 12351243.
  • Yang JH, Jia YX, Pan CS, Zhao J, Ouyang M, Yang J et al. (2005). Effects of intermedin(1-53) on cardiac function and ischemia/reperfusion injury in isolated rat hearts. Biochem Biophys Res Commun 327: 713719.
  • Yang JH, Pan CS, Jia YX, Zhang J, Zhao J, Pang YZ et al. (2006). Intermedin1–53 activates L-arginine/nitric oxide synthase/nitric oxide pathway in rat aortas. Biochem Biophys Res Commun 341: 567572.
  • Yang JH, Cai Y, Duan XH, Ma CG, Wang X, Tang CS et al. (2009). Intermedin 1–53 inhibits rat cardiac fibroblast activation induced by angiotensin II. Regul Pept 158: 1925.
  • Zeng Q, Yuan Y, Wang X, Wu HM, Fan L, Qi YF et al. (2009). Upregulated expression of intermedin and its receptor in the myocardium and aorta in spontaneously hypertensive rats. Peptides 30: 391399.
  • Zhao Y, Bell D, Smith LR, Zhao L, Devine AB, McHenry EM et al. (2006). Differential expression of components of the cardiomyocyte adrenomedullin/intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension. J Pharmacol Exp Ther 316: 12691281.